Dashboard
Manage Tickers

AKYAAkoya Biosciences, Inc.


$ 2.88 $ -0.06 (-2.04 %)    

Tuesday, 17-Sep-2024 15:59:34 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 2.86
$ 2.87 x 100
-- x --
$ 2.86 - $ 2.93
$ 1.88 - $ 6.31
240,127
na
142.56M
$ 1.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

piper-sandler-maintains-overweight-on-akoya-biosciences-lowers-price-target-to-4
Piper Sandler Maintains Overweight on Akoy...
08/13/2024 11:11:08

Piper Sandler analyst David Westenberg maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price targ...

morgan-stanley-downgrades-akoya-biosciences-to-equal-weight-lowers-price-target-to-3
Morgan Stanley Downgrades Akoya Bioscience...
08/06/2024 16:59:02

Morgan Stanley analyst Tejas Savant downgrades Akoya Biosciences (NASDAQ:AKYA) from Overweight to Equal-Weight and lowers th...

btig-downgrades-akoya-biosciences-to-neutral
BTIG Downgrades Akoya Biosciences to Neutral
08/06/2024 16:31:18

BTIG analyst Mark Massaro downgrades Akoya Biosciences (NASDAQ:AKYA) from Buy to Neutral.

a-closer-look-at-4-analyst-recommendations-for-akoya-biosciences
A Closer Look at 4 Analyst Recommendations...
08/06/2024 16:00:15

craig-hallum-maintains-buy-on-akoya-biosciences-lowers-price-target-to-7
Craig-Hallum Maintains Buy on Akoya Biosci...
08/06/2024 14:52:41

Craig-Hallum analyst Bill Bonello maintains Akoya Biosciences (NASDAQ:AKYA) with a Buy and lowers the price target from $7.5...

jp-morgan-downgrades-akoya-biosciences-to-neutral
JP Morgan Downgrades Akoya Biosciences to ...
08/06/2024 11:39:20

JP Morgan analyst Rachel Vatnsdal downgrades Akoya Biosciences (NASDAQ:AKYA) from Overweight to Neutral.

akoya-biosciences-sees-fy24-revenue-96m-104m-vs-1032m-estimate
Akoya Biosciences Sees FY24 Revenue $96M-$...
08/05/2024 20:46:15

akoya-biosciences-q2-2024-gaap-eps-027-inline-sales-23164m-miss-23552m-estimate
Akoya Biosciences Q2 2024 GAAP EPS $(0.27)...
08/05/2024 20:02:09

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.27) per share which met the analyst consensus estimate. The c...

analyst-scoreboard-4-ratings-for-akoya-biosciences
Analyst Scoreboard: 4 Ratings For Akoya Bi...
06/03/2024 14:00:34

morgan-stanley-maintains-overweight-on-akoya-biosciences-lowers-price-target-to-4
Morgan Stanley Maintains Overweight on Ako...
06/03/2024 13:05:23

Morgan Stanley analyst Tejas Savant maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price target ...

canaccord-genuity-maintains-buy-on-akoya-biosciences-lowers-price-target-to-6
Canaccord Genuity Maintains Buy on Akoya B...
05/14/2024 17:32:14

Canaccord Genuity analyst Kyle Mikson maintains Akoya Biosciences (NASDAQ:AKYA) with a Buy and lowers the price target from ...

why-alibaba-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Alibaba Shares Are Trading Lower By Ar...
05/14/2024 17:30:43

btig-maintains-buy-on-akoya-biosciences-lowers-price-target-to-6
BTIG Maintains Buy on Akoya Biosciences, L...
05/14/2024 17:01:49

BTIG analyst Mark Massaro maintains Akoya Biosciences (NASDAQ:AKYA) with a Buy and lowers the price target from $9 to $6.

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 16:31:13

why-alcon-shares-are-trading-higher-by-over-10-here-are-20-stocks-moving-premarket
Why Alcon Shares Are Trading Higher By Ove...
05/14/2024 12:30:32

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 12:06:42

akoya-biosciences-cuts-fy24-revenue-forecast-from-114m-118m-to-104m-112m-est-115767m
Akoya Biosciences Cuts FY24 Revenue Foreca...
05/13/2024 20:38:26

Akoya is updating its revenue outlook for the full year 2024 while maintaining its commitment to achieving operating cash flow ...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
05/13/2024 20:31:07

akoya-biosciences-q1-2024-adj-eps-039-misses-029-estimate-sales-18350m-miss-24281m-estimate
Akoya Biosciences Q1 2024 Adj EPS $(0.39) ...
05/13/2024 20:14:50

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $...

akoya-biosciences-and-neracare-enter-exclusive-agreement-to-enable-personalized-therapy-selection-for-early-stage-melanoma-patients
Akoya Biosciences And NeraCare Enter Exclu...
05/09/2024 13:02:28

Akoya Biosciences, Inc. (NASDAQ:AKYA), The Spatial Biology Company®, and NeraCare, a leading developer of laboratory tests for ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION